ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes (EXEPUMP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01140893
Recruitment Status : Unknown
Verified July 2016 by University Hospital, Caen.
Recruitment status was:  Recruiting
First Posted : June 10, 2010
Last Update Posted : August 23, 2016
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
University Hospital, Caen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2017
  Study Completion Date : No date given